Does the media refer more to HSIC or EW?

In the previous week, Henry Schein had 18 more articles in the media than Edwards Lifesciences. MarketBeat recorded 26 mentions for Henry Schein and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat Henry Schein's score of 0.65 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 7 Very Positive mention(s) 4 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AMN or EW?

In the previous week, AMN Healthcare Services had 9 more articles in the media than Edwards Lifesciences. MarketBeat recorded 17 mentions for AMN Healthcare Services and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat AMN Healthcare Services' score of 0.77 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 8 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer EW or ABT?

In the previous week, Abbott Laboratories had 29 more articles in the media than Edwards Lifesciences. MarketBeat recorded 37 mentions for Abbott Laboratories and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat Abbott Laboratories' score of 1.32 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 31 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer EW or SYK?

In the previous week, Stryker had 23 more articles in the media than Edwards Lifesciences. MarketBeat recorded 31 mentions for Stryker and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat Stryker's score of 0.86 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stryker 14 Very Positive mention(s) 8 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ISRG or EW?

In the previous week, Intuitive Surgical had 12 more articles in the media than Edwards Lifesciences. MarketBeat recorded 20 mentions for Intuitive Surgical and 8 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 1.61 beat Edwards Lifesciences' score of 1.44 indicating that Intuitive Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 18 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Edwards Lifesciences 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Edwards Lifesciences (EW) Competitors

$89.65 +0.33 (+0.37%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$89.72 +0.07 (+0.08%)

As of 08/7/2026 07:51 PM Eastern

Compare

EW vs. HSIC, AMN, ABT, SYK, and ISRG

Should you buy Edwards Lifesciences stock or one of its competitors? MarketBeat compares Edwards Lifesciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Edwards Lifesciences include Henry Schein (HSIC), AMN Healthcare Services (AMN), Abbott Laboratories (ABT), Stryker (SYK), and Intuitive Surgical (ISRG). These companies are all part of the "healthcare" sector.

How does Edwards Lifesciences compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Edwards Lifesciences (NYSE:EW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Henry Schein currently has a consensus target price of $92.27, suggesting a potential upside of 4.69%. Edwards Lifesciences has a consensus target price of $100.27, suggesting a potential upside of 11.85%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, analysts clearly believe Edwards Lifesciences is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Edwards Lifesciences has a net margin of 15.43% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Edwards Lifesciences	15.43%	15.68%	12.05%

Edwards Lifesciences has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.60B	0.72	$398M	$3.43	25.69
Edwards Lifesciences	$6.07B	8.51	$1.07B	$1.74	51.52

In the previous week, Henry Schein had 18 more articles in the media than Edwards Lifesciences. MarketBeat recorded 26 mentions for Henry Schein and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat Henry Schein's score of 0.65 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	7 Very Positive mention(s)	4 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market.

Summary

Edwards Lifesciences beats Henry Schein on 10 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Edwards Lifesciences (NYSE:EW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

Edwards Lifesciences has a net margin of 15.43% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 20.48% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	20.48%	5.99%
Edwards Lifesciences	15.43%	15.68%	12.05%

AMN Healthcare Services currently has a consensus price target of $30.86, suggesting a potential downside of 14.12%. Edwards Lifesciences has a consensus price target of $100.27, suggesting a potential upside of 11.85%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts clearly believe Edwards Lifesciences is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

In the previous week, AMN Healthcare Services had 9 more articles in the media than Edwards Lifesciences. MarketBeat recorded 17 mentions for AMN Healthcare Services and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat AMN Healthcare Services' score of 0.77 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	8 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

AMN Healthcare Services has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Edwards Lifesciences has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.51	-$95.70M	-$0.87	N/A
Edwards Lifesciences	$6.07B	8.51	$1.07B	$1.74	51.52

Summary

Edwards Lifesciences beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Abbott Laboratories?

Edwards Lifesciences (NYSE:EW) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Edwards Lifesciences has a net margin of 15.43% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Abbott Laboratories	11.65%	17.69%	9.44%

Abbott Laboratories has higher revenue and earnings than Edwards Lifesciences. Abbott Laboratories is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.51	$1.07B	$1.74	51.52
Abbott Laboratories	$44.33B	4.21	$6.52B	$3.09	34.89

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Abbott Laboratories had 29 more articles in the media than Edwards Lifesciences. MarketBeat recorded 37 mentions for Abbott Laboratories and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat Abbott Laboratories' score of 1.32 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	31 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Edwards Lifesciences has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

Edwards Lifesciences currently has a consensus price target of $100.27, indicating a potential upside of 11.85%. Abbott Laboratories has a consensus price target of $118.17, indicating a potential upside of 9.61%. Given Edwards Lifesciences' higher possible upside, research analysts clearly believe Edwards Lifesciences is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.96

Summary

Abbott Laboratories beats Edwards Lifesciences on 9 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to Stryker?

Edwards Lifesciences (NYSE:EW) and Stryker (NYSE:SYK) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Edwards Lifesciences has a net margin of 15.43% compared to Stryker's net margin of 14.43%. Stryker's return on equity of 23.63% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Stryker	14.43%	23.63%	11.39%

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 77.1% of Stryker shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 4.6% of Stryker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Edwards Lifesciences has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Stryker has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

Edwards Lifesciences currently has a consensus price target of $100.27, suggesting a potential upside of 11.85%. Stryker has a consensus price target of $386.28, suggesting a potential upside of 14.00%. Given Stryker's stronger consensus rating and higher possible upside, analysts plainly believe Stryker is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Stryker	0 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.83

Stryker has higher revenue and earnings than Edwards Lifesciences. Stryker is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.51	$1.07B	$1.74	51.52
Stryker	$25.84B	5.03	$3.25B	$9.65	35.11

In the previous week, Stryker had 23 more articles in the media than Edwards Lifesciences. MarketBeat recorded 31 mentions for Stryker and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.44 beat Stryker's score of 0.86 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stryker	14 Very Positive mention(s)	8 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Stryker beats Edwards Lifesciences on 9 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

Intuitive Surgical has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Intuitive Surgical is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	13.30	$2.86B	$8.73	43.39
Edwards Lifesciences	$6.07B	8.51	$1.07B	$1.74	51.52

In the previous week, Intuitive Surgical had 12 more articles in the media than Edwards Lifesciences. MarketBeat recorded 20 mentions for Intuitive Surgical and 8 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 1.61 beat Edwards Lifesciences' score of 1.44 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	18 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Edwards Lifesciences	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Intuitive Surgical has a net margin of 28.45% compared to Edwards Lifesciences' net margin of 15.43%. Intuitive Surgical's return on equity of 16.91% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.45%	16.91%	14.83%
Edwards Lifesciences	15.43%	15.68%	12.05%

Intuitive Surgical currently has a consensus price target of $509.02, indicating a potential upside of 34.37%. Edwards Lifesciences has a consensus price target of $100.27, indicating a potential upside of 11.85%. Given Intuitive Surgical's higher possible upside, equities analysts clearly believe Intuitive Surgical is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	2.66
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Summary

Intuitive Surgical beats Edwards Lifesciences on 14 of the 16 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EW vs. The Competition

Export

Metric	Edwards Lifesciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$51.43B	$5.71B	$6.92B	$24.09B
Dividend Yield	N/A	1.79%	2.59%	3.71%
P/E Ratio	51.52	24.29	271.39	29.26
Price / Sales	8.51	40.08	598.32	18.32
Price / Cash	31.32	32.81	71.46	32.96
Price / Book	4.81	5.70	13.25	6.87
Net Income	$1.07B	$148.58M	$3.45B	$1.06B
7 Day Performance	4.04%	4.75%	4.67%	2.91%
1 Month Performance	-4.26%	1.35%	-0.79%	3.43%
1 Year Performance	14.39%	4.94%	76.94%	20.31%

Edwards Lifesciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EW Edwards Lifesciences	3.928 of 5 stars	$89.65 +0.4%	$100.27 +11.8%	+15.2%	$51.43B	$6.07B	51.52	16,000	Positive News
HSIC Henry Schein	3.6808 of 5 stars	$86.51 +0.9%	$89.36 +3.3%	+33.7%	$9.77B	$13.18B	26.14	25,000	Earnings Report Analyst Forecast
AMN AMN Healthcare Services	2.7118 of 5 stars	$33.00 -1.9%	$29.00 -12.1%	+112.4%	$1.30B	$3.42B	N/A	2,664	Trending News Earnings Report Analyst Forecast
ABT Abbott Laboratories	4.5599 of 5 stars	$107.16 +1.4%	$118.17 +10.3%	-18.4%	$182.90B	$44.33B	34.68	115,000	Trending News Analyst Upgrade
SYK Stryker	4.8791 of 5 stars	$340.73 +4.6%	$386.28 +13.4%	-9.9%	$124.86B	$25.12B	35.31	56,000	Dividend Announcement Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EW) was last updated on 8/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, SYK, and ISRG

How does Edwards Lifesciences compare to Henry Schein?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Summary

How does Edwards Lifesciences compare to Stryker?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, SYK, and ISRG

How does Edwards Lifesciences compare to Henry Schein?

Do institutionals & insiders have more ownership in HSIC or EW?

Do analysts recommend HSIC or EW?

Is HSIC or EW more profitable?

Which has better earnings & valuation, HSIC or EW?

Does the media refer more to HSIC or EW?

Which has more volatility and risk, HSIC or EW?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Is AMN or EW more profitable?

Do analysts prefer AMN or EW?

Does the media refer more to AMN or EW?

Do insiders and institutionals hold more shares of AMN or EW?

Which has more risk and volatility, AMN or EW?

Which has preferable earnings and valuation, AMN or EW?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Is EW or ABT more profitable?

Which has stronger valuation and earnings, EW or ABT?

Do institutionals & insiders believe in EW or ABT?

Does the media prefer EW or ABT?

Which has more risk & volatility, EW or ABT?

Do analysts rate EW or ABT?

Summary

How does Edwards Lifesciences compare to Stryker?

Is EW or SYK more profitable?

Do institutionals and insiders hold more shares of EW or SYK?

Which has more risk & volatility, EW or SYK?

Do analysts prefer EW or SYK?

Which has better valuation & earnings, EW or SYK?

Does the media prefer EW or SYK?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Which has more volatility & risk, ISRG or EW?

Do insiders & institutionals have more ownership in ISRG or EW?

Which has better earnings & valuation, ISRG or EW?

Does the media refer more to ISRG or EW?

Is ISRG or EW more profitable?

Do analysts prefer ISRG or EW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools